Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Experimental & Molecular Medicine ; : e36-2013.
Article in English | WPRIM | ID: wpr-35841

ABSTRACT

Leucine-rich repeat kinase 2 (LRRK2) is a gene that, upon mutation, causes autosomal-dominant familial Parkinson's disease (PD). Yeast two-hybrid screening revealed that Snapin, a SNAP-25 (synaptosomal-associated protein-25) interacting protein, interacts with LRRK2. An in vitro kinase assay exhibited that Snapin is phosphorylated by LRRK2. A glutathione-S-transferase (GST) pull-down assay showed that LRRK2 may interact with Snapin via its Ras-of-complex (ROC) and N-terminal domains, with no significant difference on interaction of Snapin with LRRK2 wild type (WT) or its pathogenic mutants. Further analysis by mutation study revealed that Threonine 117 of Snapin is one of the sites phosphorylated by LRRK2. Furthermore, a Snapin T117D phosphomimetic mutant decreased its interaction with SNAP-25 in the GST pull-down assay. SNAP-25 is a component of the SNARE (Soluble NSF Attachment protein REceptor) complex and is critical for the exocytosis of synaptic vesicles. Incubation of rat brain lysate with recombinant Snapin T117D, but not WT, protein caused decreased interaction of synaptotagmin with the SNARE complex based on a co-immunoprecipitation assay. We further found that LRRK2-dependent phosphorylation of Snapin in the hippocampal neurons resulted in a decrease in the number of readily releasable vesicles and the extent of exocytotic release. Combined, these data suggest that LRRK2 may regulate neurotransmitter release via control of Snapin function by inhibitory phosphorylation.


Subject(s)
Animals , Female , Humans , Mice , Rats , Amino Acid Sequence , Exocytosis , HEK293 Cells , Molecular Sequence Data , Mutant Proteins/metabolism , Phosphorylation , Phosphothreonine/metabolism , Protein Binding , Protein Interaction Mapping , Protein Structure, Tertiary , Protein Serine-Threonine Kinases/metabolism , Qa-SNARE Proteins/metabolism , Rats, Sprague-Dawley , Synaptosomal-Associated Protein 25/metabolism , Synaptotagmins/metabolism , Vesicle-Associated Membrane Protein 2/metabolism , Vesicular Transport Proteins/chemistry
2.
Biol. Res ; 39(3): 555-566, 2006. ilus, tab
Article in English | LILACS | ID: lil-437387

ABSTRACT

During pregnancy and the perinatal period of life, prolactin (PRL) and other lactogenic substances induce adaptation and maturation of the stimulus-secretion coupling system in pancreatic â-cells. Since the SNARE molecules, SNAP-25, syntaxin 1, VAMP-2, and synaptotagmins participate in insulin secretion, we investigated whether the improved secretory response to glucose during these periods involves alteration in the expression of these proteins. mRNA was extracted from neonatal rat islets cultured for 5 days in the presence of PRL and from pregnant rats (17th-18th days of pregnancy) and reverse transcribed. The expression of genes was analyzed by semi-quantitative RT-PCR assay. The expression of proteins was analyzed by Western blotting and confocal microscopy. Transcription and expression of all SNARE genes and proteins were increased in islets from pregnant and PRL-treated neonatal rats when compared with controls. The only exception was VAMP-2 production in islets from pregnant rats. Increased mRNA and protein expression of synaptotagmin IV, but not the isoform I, also was observed in islets from pregnant and PRL-treated rats. This effect was not inhibited by wortmannin or PD098059, inhibitors of the PI3-kinase and MAPK pathways, respectively. As revealed by confocal laser microscopy, both syntaxin 1A and synaptotagmin IV were immunolocated in islet cells, including the insulin-containing cells. These results indicate that PRL modulates the final steps of insulin secretion by increasing the expression of proteins involved in membrane fusion.


Subject(s)
Animals , Female , Pregnancy , Rats , Gene Expression Regulation, Developmental/genetics , Insulin , Islets of Langerhans , Prolactin/pharmacology , SNARE Proteins/genetics , Synaptotagmins/genetics , Animals, Newborn , Blotting, Western , Electrophoresis, Polyacrylamide Gel , Gene Expression Regulation, Developmental/drug effects , Immunoblotting , Immunochemistry , Insulin/genetics , Islets of Langerhans/drug effects , Islets of Langerhans/embryology , Microscopy, Confocal , Reverse Transcriptase Polymerase Chain Reaction , RNA, Messenger/analysis , SNARE Proteins/metabolism , /genetics , /metabolism , Synaptotagmins/metabolism , Syntaxin 1/genetics , Syntaxin 1/metabolism , /genetics , /metabolism
3.
Yonsei Medical Journal ; : 70-77, 2006.
Article in English | WPRIM | ID: wpr-116917

ABSTRACT

Synaptotagmin is a Ca2+ sensing protein, which triggers a fusion of synaptic vesicles in neuronal transmission. Little is known regarding the expression of Ca2+ - dependent synaptotagmin isoforms and their contribution to the release of secretory vesicles in mouse and rat parotid acinar cells. We investigated a type of Ca2+ - dependent synaptotagmin and Ca2+ signaling in both rat and mouse parotid acinar cells using RT-PCR, microfluorometry, and amylase assay. Mouse parotid acinar cells exhibited much more sensitive amylase release in response to muscarinic stimulation than did rat parotid acinar cells. However, transient [Ca2+]i increases and Ca2+ influx in response to muscarinic stimulation in both cells were identical, suggesting that the expression or activity of the Ca2+ sensing proteins is different. Seven Ca2+ - dependent synaptotagmins, from 1 to 7, were expressed in the mouse parotid acinar cells. However, in the rat parotid acinar cells, only synaptotagmins 1, 3, 4 and 7 were expressed. These results indicate that the expression of Ca2+ - dependent synaptotagmins may contribute to the release of secretory vesicles in parotid acinar cells.


Subject(s)
Rats , Mice , Animals , Synaptotagmins/metabolism , Signal Transduction , Protein Isoforms/metabolism , Parotid Gland/cytology , Muscarinic Agonists/pharmacology , Exocytosis/drug effects , Carbachol/pharmacology , Calcium/metabolism , Amylases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL